Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Zachariah Holmes
ID:
1b83cf18-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
31 articles
Teva and Polpharma Biologics Announce Global Licensing Agreement for Ocrelizumab Biosimilar for Multiple Sclerosis
Big Molecule Watch ·
July 15, 2026
cite
Alvotech’s BLA for Vedolizumab Biosimilar First to be Accepted by FDA
Big Molecule Watch ·
June 10, 2026
cite
FDA Approves Lannett, Lanexa Biologics, and Sunshine Lake Pharma’s Interchangeable Insulin Glargine Biosimilar
Big Molecule Watch ·
May 11, 2026
cite
Vera Therapeutics Submits BLA to FDA for Atacicept Fusion Protein
Big Molecule Watch ·
November 17, 2025
cite
Kashiv BioSciences Omalizumab Biosimilar Application Submitted to FDA, Accepted by EMA
Big Molecule Watch ·
October 9, 2025
cite
Previous
1
2
...
7
Next
